LEE ANN L. 4
4 · Prime Medicine, Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
LEE ANN L.
Chief Technical Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-08+80,416→ 241,248 totalExercise: $3.67Exp: 2031-10-27→ Common Stock (80,416 underlying)
Footnotes (1)
- [F1]Represents an option initially granted to the Reporting Person on October 27, 2021, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On May 8, 2025, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 80,416 shares.